Aceso Life Science Group Limited - Net Worth and Insider Trading

Aceso Life Science Group Limited Net Worth

The estimated net worth of Aceso Life Science Group Limited is at least $874 Million dollars as of 2024-11-07. Aceso Life Science Group Limited is the 2201 Interest of corporation controlled by you of Hao Tian International Construction Investment Group Ltd and owns about 2,211,613,259 shares of Hao Tian International Construction Investment Group Ltd (HKSE:01341) stock worth over $874 Million. Details can be seen in Aceso Life Science Group Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aceso Life Science Group Limited has not made any transactions after 2023-10-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Aceso Life Science Group Limited

Aceso Life Science Group Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aceso Life Science Group Limited owns 1 companies in total, including Hao Tian International Construction Investment Group Ltd (HKSE:01341) .

Click here to see the complete history of Aceso Life Science Group Limited’s form 4 insider trades.

Insider Ownership Summary of Aceso Life Science Group Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:01341	Hao Tian International Construction Investment Group Ltd	2023-10-13	2201 Interest of corporation controlled by you

Aceso Life Science Group Limited Latest Holdings Summary

Aceso Life Science Group Limited currently owns a total of 1 stock. Aceso Life Science Group Limited owns 2,211,613,259 shares of Hao Tian International Construction Investment Group Ltd (HKSE:01341) as of October 13, 2023, with a value of $874 Million.

Latest Holdings of Aceso Life Science Group Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01341	Hao Tian International Construction Investment Group Ltd	2023-10-13	2,211,613,259	0.40	873,587,237

Holding Weightings of Aceso Life Science Group Limited

Aceso Life Science Group Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Aceso Life Science Group Limited has made a total of 3 transactions in Hao Tian International Construction Investment Group Ltd (HKSE:01341) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Hao Tian International Construction Investment Group Ltd is the sale of 1,400,088,000 shares on October 13, 2023, which brought Aceso Life Science Group Limited around $0.

Insider Trading History of Aceso Life Science Group Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aceso Life Science Group Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Aceso Life Science Group Limited Ownership Network

Ownership Network List of Aceso Life Science Group Limited

No Data

Ownership Network Relation of Aceso Life Science Group Limited

Aceso Life Science Group Limited Owned Company Details

What does Hao Tian International Construction Investment Group Ltd do?

Who are the key executives at Hao Tian International Construction Investment Group Ltd?

Aceso Life Science Group Limited is the 2201 Interest of corporation controlled by you of Hao Tian International Construction Investment Group Ltd. Other key executives at Hao Tian International Construction Investment Group Ltd include 2201 Interest of corporation controlled by you Asia Link Capital Investment Holdings Limited , 2201 Interest of corporation controlled by you Win Team Investments Limited , and 2101 Beneficial owner Hao Tian Management (china) Limited .

Hao Tian International Construction Investment Group Ltd (HKSE:01341) Insider Trades Summary

Over the past 18 months, Aceso Life Science Group Limited made 1 insider transaction in Hao Tian International Construction Investment Group Ltd (HKSE:01341) with a net sale of 1,400,088,000. Other recent insider transactions involving Hao Tian International Construction Investment Group Ltd (HKSE:01341) include a net sale of 1,400,088,000 shares made by Win Team Investments Limited , a net sale of 1,400,088,000 shares made by Li Shao Yu , and a net sale of 1,400,088,000 shares made by Asia Link Capital Investment Holdings Limited .

In summary, during the past 3 months, insiders sold 0 shares of Hao Tian International Construction Investment Group Ltd (HKSE:01341) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,000,440,000 shares of Hao Tian International Construction Investment Group Ltd (HKSE:01341) were sold and 1,400,088,000 shares were bought by its insiders, resulting in a net sale of 5,600,352,000 shares.

Hao Tian International Construction Investment Group Ltd (HKSE:01341)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hao Tian International Construction Investment Group Ltd Insider Transactions

No Available Data

Aceso Life Science Group Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Aceso Life Science Group Limited. Currently GuruFocus does not have mailing address information for Aceso Life Science Group Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.